Future of Netupitant - Palonosetron FDC Market with Deep Analysis by 2018
The global chemotherapy-induced nausea and vomiting (CINV) market is expected to reach USD 1.7 billion by 2015, due to prevalent cancer related conditions and subsequent increase in the CINV pool. The global CINV patient pool is estimated to reach 4.6 million by 2015. The Asian region is expected to witness the largest patient share for CINV contributing majorly to the total CINV patient pool thereby presenting a huge potential for the Netupitant - Palonosetron market. This report initially starts with...
View full press release